How bioinformatics influences health informatics: Usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health

Health Information Science and Systems

Volumn 1, Issue 1, 2013, Pages

  Kuznetsov, Vladimir ^a,b   Lee, Hwee K ^a   Maurer Stroh, Sebastian ^a,c   Molnár, Maria J ^d   Pongor, Sandor ^e   Eisenhaber, Birgit ^a   Eisenhaber, Frank ^a,b,f  

^a BIOINFORMATICS INSTITUTE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d Institute of Genomic Medicine and Rare Disorders   (Hungary)

^e PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

AIDS; Bioinformatics; Cancer biomarker; Cancer mutation; Digital pathology; Dry eye; Enterohemorrhagic Escherichia coli; Expression profiling; Genome sequencing; Glaucoma; H1N1; Histopathological bioimaging; HIV; Influenza; Quorum sensing; Tumor segmentation

Indexed keywords

ABELSON KINASE; AMIKACIN; BCR ABL PROTEIN; BIOLOGICAL MARKER; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMATINIB; IMIPENEM; JANUS KINASE; KANAMYCIN; MEROPENEM; MITOGEN ACTIVATED PROTEIN KINASE; NITROFURANTOIN; PAIRED BOX TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RAC PROTEIN; RAS PROTEIN; STAT PROTEIN; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN; UNINDEXED DRUG;

AUTOANALYSIS; BIOINFORMATICS; CANCER CLASSIFICATION; CANCER PROGNOSIS; CLINICAL TRIAL (TOPIC); CLOSED ANGLE GLAUCOMA; COMPUTER; COMPUTER ASSISTED SURGERY; DERMATOLOGY; DRY EYE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENE EXPRESSION; GENOMICS; HEALTH CARE; HUMAN; IMAGE ANALYSIS; IMAGING; INFECTION; INFLUENZA VIRUS; MEDICAL INFORMATICS; MUTATION; NEOPLASM; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEOMICS; PUBLIC HEALTH; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 84892915273     PISSN: None     EISSN: 20472501     Source Type: Journal    
DOI: 10.1186/2047-2501-1-2     Document Type: Review

References (119)

1. Eisenhaber F. A decade after the first full human genome sequencing: When will we understand our own genome?. J Bioinformatics Comp Biol 2012, 10:12710.
2. The Human Genome Project Completion: Frequently Asked Questions 3-26-2012 http://www.genome.gov/11006943, The Human Genome Project Completion: Frequently Asked Questions.
3. Sequencing competition heats up 3-28-2012 http://rna-seqblog.com/news/sequencing-competition-heats-up/, Sequencing competition heats up.
4. Eisenhaber F. Bioinformatics: Mystery, Astrology or Service Technology. Preface. Discovering Biomolecular Mechanisms with Computational Biology 2006, 1-10. Georgetown: Landes Biosciences and Eurekah.com, Eisenhaber F, 1st.
5. Bio-IT World 10th Anniversary 2002-2012 2-8-2012 http://www.bio-itworld.com/10th-Anniversary/, Bio-IT World 10th Anniversary 2002-2012.
6. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001, 285:540-544. 10.1001/jama.285.5.540, 11176855.
7. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011, 470:187-197. 10.1038/nature09792, 21307931.
8. Dethoff EA, Chugh J, Mustoe AM, Al-Hashimi HM. Functional complexity and regulation through RNA dynamics. Nature 2012, 482:322-330. 10.1038/nature10885, 3320162, 22337051.
9. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012, 482:339-346. 10.1038/nature10887, 22337053.
10. DNA-sequencing penetrates Norway's healthcare system 3-2-2012 http://www.fiercemedicaldevices.com/story/dna-sequencing-penetrates-norways-healthcare-system/2012-02-03, DNA-sequencing penetrates Norway's healthcare system.
11. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, Bainbridge M, Dinh H, Jing C, Wheeler DA, et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010, 362:1181-1191. 10.1056/NEJMoa0908094, 20220177.
12. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, et al. The NIH Human Microbiome Project. Genome Res 2009, 19:2317-2323. 2792171, 19819907.
13. Hajibabaei M, Singer GA, Hebert PD, Hickey DA. DNA barcoding: how it complements taxonomy, molecular phylogenetics and population genetics. Trends Genet 2007, 23:167-172. 10.1016/j.tig.2007.02.001, 17316886.
14. Kozarewa I, Turner DJ. 96-plex molecular barcoding for the Illumina Genome Analyzer. Methods Mol Biol 2011, 733:279-298. 10.1007/978-1-61779-089-8_20, 21431778.
15. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009, 458:719-724. 10.1038/nature07943, 2821689, 19360079.
16. Singapore Cancer Registry Trends in cancer incidence in Singapore 2001-2005. Singapore Cancer Registry interim report 2008, Singapore Cancer Registry.
17. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 2007, 6:287-293. 10.1038/nrd2251, 17380152.
18. Valencia A, Hidalgo M. Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics. Genome Med 2012, 4:61.
19. Kris NG, Meropol NJ, Winer EP. ASCO's Blueprint for Transforming Clinical and Translational Cancer Research, November 2011 2011, Alexandria, VA: American Society of Clinical Oncology, 3536736, 23301067.
20. Sequist LV, Heist RS, Shaw AT, Fidias P, Rosovsky R, Temel JS, Lennes IT, Digumarthy S, Waltman BA, Bast E, et al. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol 2011, 22:2616-2624. 10.1093/annonc/mdr489, 3493130, 22071650.
21. Ion AmpliSeq™ Cancer Panel 8-10-2012 http://www.iontorrent.com/lib/images/PDFs/ampliseq%20appnote.pdf, Ion AmpliSeq™ Cancer Panel.
22. Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med 2007, 357:258-265. 10.1056/NEJMct071828, 17634461.
23. Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer 2007, 7:345-356. 10.1038/nrc2126, 17457302.
24. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011, 364:2507-2516. 10.1056/NEJMoa1103782, 3549296, 21639808.
25. Poulikakos PI, Persaud Y, Janakiraman M, Kong X, Ng C, Moriceau G, Shi H, Atefi M, Titz B, Gabay MT, et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 2011, 480:387-390. 10.1038/nature10662, 3266695, 22113612.
26. Saintigny P, Burger JA. Recent advances in non-small cell lung cancer biology and clinical management. Discov Med 2012, 13:287-297.
27. Toh SH, Prathipati P, Motakis E, Kwoh CK, Yenamandra SP, Kuznetsov VA. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma. BMC Genomics 2011, 12(Suppl 3):S24. 10.1186/1471-2164-12-S3-S24, 3377915, 22369099.
28. Motakis E, Ivshina AV, Kuznetsov VA. Data-driven approach to predict survival of cancer patients: estimation of microarray genes' prediction significance by Cox proportional hazard regression model. IEEE Eng Med Biol Mag 2009, 28:58-66.
29. Grinchuk OV, Motakis E, Kuznetsov VA. Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression. BMC Genomics 2010, 11(Suppl 1):S9. 10.1186/1471-2164-11-S1-S9, 3045802, 21210975.
30. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006, 66:10292-10301. 10.1158/0008-5472.CAN-05-4414, 17079448.
31. Bard-Chapeau EA, Jeyakani J, Kok CH, Muller J, Chua BQ, Gunaratne J, Batagov A, Jenjaroenpun P, Kuznetsov VA, Wei CL, et al. Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors. Proc Natl Acad Sci U S A 2012, 109:2168-2173. 10.1073/pnas.1119229109, 3277513, 22308434.
32. Batagov AO, Kuznetsov VA, Kurochkin IV. Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics 2011, 12(Suppl 3):S18. 10.1186/1471-2164-12-S3-S18, 3333177, 22369587.
33. Sirota FL, Batagov A, Schneider G, Eisenhaber B, Eisenhaber F, Maurer-Stroh S. Beware of moving targets: reference proteome content fluctuates substantially over the years. J Bioinform Comput Biol 2012, 10:1250020. 10.1142/S0219720012500205, 22867629.
34. Vogel M, Schwarze-Zander C, Wasmuth JC, Spengler U, Sauerbruch T, Rockstroh JK. The treatment of patients with HIV. Dtsch Arztebl Int 2010, 107:507-515. 2915483, 20703338.
35. Wilson LE, Gallant JE. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations. Clin Infect Dis 2009, 48:214-221. 10.1086/595701, 19072245.
36. Eberle J, Gurtler L. The evolution of drug resistance interpretation algorithms: ANRS, REGA and extension of resistance analysis to HIV-1 group O and HIV-2. Intervirology 2012, 55:128-133. 10.1159/000332009, 22286882.
37. Martinez-Cajas JL, Wainberg MA. Antiretroviral therapy: optimal sequencing of therapy to avoid resistance. Drugs 2008, 68:43-72. 10.2165/00003495-200868010-00004, 18081372.
38. Gianella S, Richman DD. Minority variants of drug-resistant HIV. J Infect Dis 2010, 202:657-666. 10.1086/655397, 2916955, 20649427.
39. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Genet Evol 2008, 8:747-763. 10.1016/j.meegid.2008.07.007, 18718557.
40. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201. 10.1126/science.1176225, 3250984, 19465683.
41. Maurer-Stroh S, Ma J, Lee RT, Sirota FL, Eisenhaber F. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biol Direct 2009, 4:18. 10.1186/1745-6150-4-18, 2691737, 19457254.
42. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459:1122-1125. 10.1038/nature08182, 19516283.
43. Kilander A, Rykkvin R, Dudman SG, Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 2010, 15:19498.
44. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312:404-410. 10.1126/science.1124513, 16543414.
45. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440:435-436. 10.1038/440435a, 16554799.
46. Watanabe T, Shinya K, Watanabe S, Imai M, Hatta M, Li C, Wolter BF, Neumann G, Hanson A, Ozawa M, et al. Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J Virol 2011, 85:13195-13203. 10.1128/JVI.00859-11, 3233164, 21937653.
47. Maurer-Stroh S, Lee RT, Eisenhaber F, Cui L, Phuah SP, Lin RT. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr 2010, 2:RRN1162. 2880458, 20535229.
48. Barr IG, Cui L, Komadina N, Lee RT, Lin RT, Deng Y, Caldwell N, Shaw R, Maurer-Stroh S. A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill 2010, 15:19692.
49. Inoue M, Barkham T, Leo YS, Chan KP, Chow A, Wong CW, Tze Chuen LR, Maurer-Stroh S, Lin R, Lin C. Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours. Emerg Infect Dis 2010, 16:1633-1636. 10.3201/eid1610.100688, 3294403, 20875299.
50. Hurt AC, Lee RT, Leang SK, Cui L, Deng YM, Phuah SP, Caldwell N, Freeman K, Komadina N, Smith D, et al. Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill 2011, 16:19884.
51. Nguyen HT, Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, Ades EW, Klimov AI, Fry AM, Gubareva LV. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States. Antiviral Res 2012, 93:381-386. 10.1016/j.antiviral.2012.01.006, 22330888.
52. Van der Vries E, Veldhuis Kroeze EJ, Stittelaar KJ, Linster M, der LA V, Schrauwen EJ, Leijten LM, Van AG, Schutten M, Kuiken T, et al. Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets. PLoS Pathog 2011, 7:e1002276. 10.1371/journal.ppat.1002276, 3182921, 21980293.
53. Frank C, Faber MS, Askar M, Bernard H, Fruth A, Gilsdorf A, Hohle M, Karch H, Krause G, Prager R, et al. Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011. Euro Surveill 2011, 16.
54. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, et al. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 2011, 6:e22751. 10.1371/journal.pone.0022751, 3140518, 21799941.
55. Characterization of EHEC O104:H4 6-30-2011 http://www.rki.de/cln_178/nn_217400/EN/Home/EHECO104, Characterization of EHEC O104:H4.
56. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402. 10.1093/nar/25.17.3389, 146917, 9254694.
57. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011, 39:D1035-D1041. 10.1093/nar/gkq1126, 3013709, 21059682.
58. Liu B, Pop M. ARDB-Antibiotic Resistance Genes Database. Nucleic Acids Res 2009, 37:D443-D447. 10.1093/nar/gkn656, 2686595, 18832362.
59. Sibley CD, Rabin H, Surette MG. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol 2006, 1:53-61. 10.2217/17460913.1.1.53, 17661685.
60. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 2008, 4:e1000184. 10.1371/journal.ppat.1000184, 2566602, 18949036.
61. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 2008, 105:15070-15075. 10.1073/pnas.0804326105, 2567494, 18812504.
62. Hosni T, Moretti C, Devescovi G, Suarez-Moreno ZR, Fatmi MB, Guarnaccia C, Pongor S, Onofri A, Buonaurio R, Venturi V. Sharing of quorum-sensing signals and role of interspecies communities in a bacterial plant disease. ISME J 2011, 5:1857-1870. 10.1038/ismej.2011.65, 3223305, 21677694.
63. Bassler BL. Small talk. Cell-to-cell communication in bacteria. Cell 2002, 109:421-424. 10.1016/S0092-8674(02)00749-3, 12086599.
64. Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science 2006, 311:1113-1116. 10.1126/science.1121357, 2776824, 16497924.
65. Fuqua C, Parsek MR, Greenberg EP. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu Rev Genet 2001, 35:439-468. 10.1146/annurev.genet.35.102401.090913, 11700290.
66. Fuqua C, Greenberg EP. Listening in on bacteria: acyl-homoserine lactone signalling. Nat Rev Mol Cell Biol 2002, 3:685-695. 10.1038/nrm907, 12209128.
67. Collier DN, Anderson L, McKnight SL, Noah TL, Knowles M, Boucher R, Schwab U, Gilligan P, Pesci EC. A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett 2002, 215:41-46. 10.1111/j.1574-6968.2002.tb11367.x, 12393198.
68. Gelencsér Z, Choudhary KS, Coutinho BG, Hudaiberdiev S, Galbáts B, Venturi V, Pongor S. Classifying the topology of AHL-driven quorum sensing circuits in proteobacterial genomes. Sensors 2012, 12:5432-5444. 10.3390/s120505432, 3386692, 22778593.
69. Gelencsér Z, Galbáts B, Gonzalez JF, Choudhary KS, Hudaiberdiev S, Venturi V, Pongor S. Chromosomal arrangement of AHL.driven quorum sensing circuits in Pseudomonas. ISRN Microbiology 2012, 2012:484176.
70. Netotea S, Bertani I, Steindler L, Kerenyi A, Venturi V, Pongor S. A simple model for the early events of quorum sensing in Pseudomonas aeruginosa: modeling bacterial swarming as the movement of an "activation zone". Biol Direct 2009, 4:6. 10.1186/1745-6150-4-6, 2660287, 19216743.
71. Venturi V, Bertani I, Kerenyi A, Netotea S, Pongor S. Co-swarming and local collapse: quorum sensing conveys resilience to bacterial communities by localizing cheater mutants in Pseudomonas aeruginosa. PLoS One 2010, 5:e9998. 10.1371/journal.pone.0009998, 2848674, 20376321.
72. Venturi V, Kerenyi A, Reiz B, Bihary D, Pongor S. Locality versus globality in bacterial signalling: can local communication stabilize bacterial communities?. Biol Direct 2010, 5:30. 10.1186/1745-6150-5-30, 2873267, 20423483.
73. Kerényi A, Suárez-Moreno ZR, Venturi V, Pongor S. Multispecies microbial communities. Part II: Principles of molecular communications. Medical Mycology 2010, 17:113-116.
74. Demir C, Yener B. Automated cancer diagnosis based on histopathological images: a systematic survey. Technical report TR-05-09 2005, Computer Science Department of Rensselaer Polytechnic Institute.
75. Huang CH, Veillard A, Roux L, Lomenie N, Racoceanu D. Time-efficient sparse analysis of histopathological whole slide images. Comput Med Imaging Graph 2011, 35:579-591. 10.1016/j.compmedimag.2010.11.009, 21145705.
76. American Cancer Society, Inc Surveillance Research, Updated March 2010 2010, American Cancer Society, Inc.
77. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992, 23:273-279. 10.1016/0046-8177(92)90108-F, 1555838.
78. Allsbrook WC, Mangold KA, Johnson MH, Lane RB, Lane CG, Epstein JI. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist. Hum Pathol 2001, 32:81-88. 10.1053/hupa.2001.21135, 11172299.
79. Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 2001, 165:851-856. 10.1016/S0022-5347(05)66543-3, 11176485.
80. Naik S, Doyle S, Agner S, Madabhushi A, Feldman M, Tomaszewski J. Automated gland and nuclei segmentation for grading prostate and breast cancer histopathology. Proc IEEE Int Symp Biomed Imaging 2008, 284-287.
81. Huang P-W, Lee C-H. Automated classification for pathological prostate images based on fractal analysis. IEEE Trans Medical Imaging 2009, 28:1037-1050.
82. Arif M, Rajpot N. Classification of potential nuclei in prostate histology images using shape manifold learning. Proc. Int Conference in Machine Vision 2007, 113-118.
83. Doyle S, Rodriguez C, Madabhushi A, Tomaszeweski J, Feldman M. Detecting prostatic adenocarcinoma from digitized histology using a multi-scale hierarchical classification approach. Conf Proc IEEE Eng Med Biol Soc 2006, 1:4759-4762.
84. Hafiane A, Bunyak F, Palaniappan K. Level set-based histology image segmentation with region-based comparison. Microscopic Image Analysis with Applications in Biology Workshop 2008, 1-6.
85. Naik S, Doyle S, Feldman M, Tomaszewski J, Madabhushi A. Gland segmentation and computerized Gleason grading of prostate cancer histology by integrating low-, high-level and domain specific information. Microscopic Image Analysis with Applications in Biology Workshop 2007, 1-8.
86. Teverovskiy M, Kumar V, Ma J, Kotsianti A, Verbel D, Tabesh A, Pang H-Y, Vengrenyuk Y, Fogarasi S, Saidi O. Improved prediction of prostate cancer reoccurrence based on an automated tissue image analysis system. IEEE Intl.Symp.Biomedical Imaging 2004, 257-260.
87. Jacques SL, Ramella-Roman JC, Lee K. Imaging skin pathology with polarized light. J Biomed Opt 2002, 7:329-340. 10.1117/1.1484498, 12175282.
88. Nakao D, Tsumura N, Miyake Y. Real-time multi-spectral image processing for mapping pigmentation in human skin. Proc 9th IS&T/SID Color Imaging Conference 1995, 9:80-84.
89. Yamada T, Saito H, Ozawa S. 3D shape inspection of skin surface from rotation of light source. Intl Conf Quality Control by Artificial Vision 1999, 245-251.
90. Liu J, Bowyer K, Goldgof D, Sarkar S. A comparative study of texture measures for human skin treatment. Intl Conf Information, Communications and Signal Processing 1997, 170-174.
91. Takemae Y, Morimaya T, Ozawa S. The correspondence between physical features and subjective evaluation on skin image. Proceedings of The 1999 IEICE General conference 1999, 268.
92. Takemae Y, Saito H, Ozawa S. The evaluating system of human skin surface condition by image processing. IEEE Intl Conf System, Man and Cybernetics 2000, 218-223.
93. Sparavigna A, Marazzato R. An image processing analysis of skin textures. Skin Res Technol 2010, 16:161-167. 10.1111/j.1600-0846.2009.00413.x, 20456096.
94. Yamada T, Saito H, Ozawa S. 3D reconstruction of skin surface from image sequence. IAPR Workshop on Machine Vision Applications 1998, 742-745.
95. Thylefors B, Negrel AD. The global impact of glaucoma. Bull World Health Organ 1994, 72:323-326. 2486713, 8062393.
96. Foster PJ, Oen FT, Machin D, Ng TP, Devereux JG, Johnson GJ, Khaw PT, Seah SK. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol 2000, 118:1105-1111.
97. Sathyamangalam RV, Paul PG, George R, Baskaran M, Hemamalini A, Madan RV, Augustian J, Prema R, Lingam V. Determinants of glaucoma awareness and knowledge in urban Chennai. Indian J Ophthalmol 2009, 57:355-360. 10.4103/0301-4738.55073, 2804123, 19700873.
98. Quigley HA, Congdon NG, Friedman DS. Glaucoma in China (and worldwide): changes in established thinking will decrease preventable blindness. Br J Ophthalmol 2001, 85:1271-1272. 10.1136/bjo.85.11.1271, 1723776, 11673284.
99. Amerasinghe N, Aung T. Angle-closure: risk factors, diagnosis and treatment. Prog Brain Res 2008, 173:31-45.
100. Nolan WP, See JL, Chew PT, Friedman DS, Smith SD, Radhakrishnan S, Zheng C, Foster PJ, Aung T. Detection of primary angle closure using anterior segment optical coherence tomography in Asian eyes. Ophthalmology 2007, 114:33-39. 10.1016/j.ophtha.2006.05.073, 17070597.
101. Cheng J, Tao D, Liu J, Wong DW, Lee BH, Baskaran M, Wong TY, Aung T. Focal biologically inspired feature for glaucoma type classification. Med Image Comput Comput Assist Interv 2011, 14:91-98.
102. Ahmed IIK, MacKeen LD. A new approach to imaging the angle. Glaucoma Today 2007, 2007:28-30.
103. Console JW, Sakata LM, Aung T, Friedman DS, He M. Quantitative analysis of anterior segment optical coherence tomography images: the Zhongshan Angle Assessment Program. Br J Ophthalmol 2008, 92:1612-1616. 10.1136/bjo.2007.129932, 18617543.
104. Wang B, Sakata LM, Friedman DS, Chan YH, He M, Lavanya R, Wong TY, Aung T. Quantitative iris parameters and association with narrow angles. Ophthalmology 2010, 117:11-17. 10.1016/j.ophtha.2009.06.017, 19815290.
105. Wang BS, Narayanaswamy A, Amerasinghe N, Zheng C, He M, Chan YH, Nongpiur ME, Friedman DS, Aung T. Increased iris thickness and association with primary angle closure glaucoma. Br J Ophthalmol 2011, 95:46-50. 10.1136/bjo.2009.178129, 20530187.
106. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 2008, 115:911-915. 10.1016/j.ophtha.2007.06.031, 18452765.
107. Koh YW, Celik T, Lee HK, Petznick A, Tong L. Detection of meibomian glands and classification of meibigraphy images. J Biomed Optics 2012, 17:086008.
108. Zhou J, Xiong W, Ding F, Qi T, Wang Z, Oo T, Venkatesh SK. Liver workbench: a tool suite for liver and liver tumor segmentation and modeling. Advances in Soft Computing 2012, 120:193-208.
109. Zhou JY, Wong DW, Ding F, Venkatesh SK, Tian Q, Qi YY, Xiong W, Liu JJ, Leow WK. Liver tumour segmentation using contrast-enhanced multi-detector CT data: performance benchmarking of three semiautomated methods. Eur Radiol 2010, 20:1738-1748. 10.1007/s00330-010-1712-z, 20157817.
110. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999, 19:271-285. 10.1055/s-2007-1007117, 10518307.
111. Zhao B, Schwartz LH, Jiang L, Colville J, Moskowitz C, Wang L, Leftowitz R, Liu F, Kalaigian J. Shape-constraint region growing for delineation of hepatic metastases on contrast-enhanced computed tomograph scans. Invest Radiol 2006, 41:753-762. 10.1097/01.rli.0000236907.81400.18, 16971799.
112. Yim PJ, Foran DJ. Volumetry of hepatic metastases in computed tomography using watershed and active contour algorithms. IEEE Symp Computer-Based Medical Systems 2003, 329-335.
113. Yim PJ, Vora AV, Raghavan D, Prasad R, McAullife M, Ohman-Strickland P, Nosher JL. Volumetric analysis of liver metastases in computed tomography with the fuzzy C-means algorithm. J Comput Assist Tomogr 2006, 30:212-220. 10.1097/00004728-200603000-00008, 16628034.
114. Ray S, Hagge R, Gillen M, Cerejo M, Shakeri S, Beckett L, Greasby T, Badawi RD. Comparison of two-dimensional and three-dimensional iterative watershed segmentation methods in hepatic tumor volumetrics. Med Phys 2008, 35:5869-5881. 10.1118/1.3013561, 2673614, 19175143.
115. Chi Y, Liu J, Venkatesh S, Huang S, Zhou J, Tian Q, Nowinski W. Segmentation of Liver Vasculature from Contrast Enhanced CT Images using Context-based Voting. IEEE Trans Biomed Eng 2011, 58:2144-2153.
116. Bai H, Ge Y, Wang J-F, Liao YL. Using rough set theory to identify villages affected by birth defects: the example of Heshun, Shanxi, China. Int J Geographical Information Science 2010, 24:559-576.
117. Kolovos A, Angulo J, Modis K, Papantonopoulos G, Wang JF, Christakos G. Model-driven development of covariances for spatiotemporal environmental health assessment. Environ Monit Assess 2012, 2012:1-17.
118. Wikimedia commons: patient body and organ 8-15-2012 http://commons.wikimedia.org/wiki/File:Symptoms_of_swine_flu.svg, Wikimedia commons: patient body and organ.
119. Wikimedia commons: infected cell 8-15-2012 http://commons.wikimedia.org/wiki/File:Virus_Replication.svg, Wikimedia commons: infected cell.